SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001114220-18-000104
Filing Date
2018-11-08
Accepted
2018-11-08 17:32:07
Documents
69
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kerx-9302018x10q.htm 10-Q 912337
2 EXHIBIT 10.1 kerx-9302018x10qex101.htm EX-10.1 50504
3 EXHIBIT 10.2 kerx-9302018x10qex102.htm EX-10.2 26844
4 EXHIBIT 31.1 kerx-9302018x10qex311.htm EX-31.1 13180
5 EXHIBIT 31.2 kerx-9302018x10qex312.htm EX-31.2 13086
6 EXHIBIT 32.1 kerx-9302018x10qex321.htm EX-32.1 6205
7 EXHIBIT 32.2 kerx-9302018x10qex322.htm EX-32.2 6240
  Complete submission text file 0001114220-18-000104.txt   4816064

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kerx-20180930.xml EX-101.INS 811586
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kerx-20180930.xsd EX-101.SCH 42999
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kerx-20180930_cal.xml EX-101.CAL 63670
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kerx-20180930_def.xml EX-101.DEF 210287
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kerx-20180930_lab.xml EX-101.LAB 540845
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kerx-20180930_pre.xml EX-101.PRE 323181
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 181170806
SIC: 2834 Pharmaceutical Preparations